drugset / Trial / NCT00680654
Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is to demonstrate the safety, tolerability, pharmakokinetic and pharmacodynamic effect of BAY63-2521 in patients with pulmonary hypertension and stable treatment of sildenafil 20 mg.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-08
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riociguat | Other / unclassified | 0.5 mg | — |
| Subject | Riociguat | Other / unclassified | 1 mg | — |